| |
| |
|
| Insider
Information: |
Ji Henry |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
6,571,078 |
|
|
Indirect Shares
|
3,458,951 |
|
|
| Direct
Value |
$70,804 |
|
|
|
Indirect Value
|
$5,011,703 |
|
|
| Total
Shares |
10,030,029 |
|
|
| Total
Value |
$5,082,506 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
| Percentage
Gain/Loss : |
 -85.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sorrento Therapeutics Inc |
SRNE |
See Remarks, Director |
2023-03-17 |
6,265,805 |
2023-03-17 |
2,331,693 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
|
0 |
2015-07-27 |
776,535 |
Premium* |
|
|
Scilex Holding Co |
SCLX |
|
2024-05-17 |
305,273 |
2024-05-17 |
350,723 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2015-07-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
776,535 |
|
- |
|
| SCLX |
Scilex Holding Co |
Executive Chairperson |
• • – |
2023-03-17 |
4 |
A |
$8.60 |
$23,479 |
I/I |
2,730 |
2,730 |
0 |
- |
|
| SCLX |
Scilex Holding Co |
Executive ChairpersonOfficer |
• • – |
2023-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
300,723 |
|
- |
|
| SCLX |
Scilex Holding Co |
Executive ChairpersonOfficer |
• • – |
2023-09-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
305,273 |
|
- |
|
| SCLX |
Scilex Holding Co |
Executive Chairperson |
• • – |
2024-05-17 |
4 |
B |
$0.88 |
$43,985 |
I/I |
50,000 |
50,070 |
0.01 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Sci. Officer & Secretary |
• • – |
2009-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,785,375 |
|
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Sci. Officer & Secretary |
• • • |
2009-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
50,968,657 |
52,754,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
• • • |
2010-04-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000,000 |
43,754,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
• • • |
2010-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,657,167 |
5,096,865 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
• • • |
2010-05-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
38,657,167 |
38,657,167 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
• • • |
2010-11-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,096,865 |
43,754,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific Officer & Sec |
• • • |
2010-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,096,865 |
0 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
• • • |
2012-02-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
450,000 |
43,304,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
• • • |
2012-03-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,000 |
43,154,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Interim CEO and CSO |
• • • |
2012-05-15 |
4 |
B |
$0.16 |
$1,000,000 |
I/I |
6,250,000 |
6,250,000 |
2.64 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • • |
2013-07-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
25,000 |
43,129,032 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • • |
2013-09-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
1,723,162 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2013-11-19 |
4 |
B |
$8.59 |
$17,189 |
I/I |
2,000 |
1,725,162 |
2.58 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2013-11-22 |
4 |
B |
$8.47 |
$8,466 |
D/D |
1,000 |
1,726,162 |
2.81 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2013-12-04 |
4 |
B |
$8.53 |
$8,536 |
D/D |
1,000 |
1,727,162 |
2.81 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2013-12-05 |
4 |
B |
$8.88 |
$8,915 |
D/D |
1,000 |
1,728,162 |
2.81 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2014-06-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(250,000) |
2,088,162 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2014-09-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
20,000 |
2,068,162 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2014-11-06 |
4 |
B |
$4.50 |
$13,600 |
D/D |
3,000 |
7,000 |
2.81 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
President and CEO |
• • – |
2014-11-07 |
4 |
B |
$4.53 |
$18,250 |
D/D |
4,000 |
11,000 |
2.81 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
